Privi Speciality Chemicals Limited has informed the Exchange about Receipt of Observation Letters from National Stock Exchange of India Limited in relation to the scheme of amalgamation between Privi Speciality Chemicals Limited ( Transferee Company/PSCL ), Privi Fine Sciences Private Limited ( Transferor Company 1/ PFSPL ) and Privi Biotechnologies Private Limited ( Transferor Company 2/ PBPL ) and their respective shareholders and creditors under sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ( Scheme ).
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Privi Speciality Chemicals Limited has received a 'no objection' observation letter from NSE regarding the proposed amalgamation of Privi Speciality Chemicals Limited (Transferee Company) with Privi Fine Sciences Private Limited (Transferor Company 1) and Privi Biotechnologies Private Limited (Transferor Company 2). The Board had approved this scheme in December 2025. The BSE observation letter is still awaited. The amalgamation is being undertaken under Sections 230-232 of the Companies Act, 2013 and remains subject to other regulatory approvals.
This is a positive regulatory milestone indicating NSE has no objection to the amalgamation. However, shareholders should note that BSE approval is still pending and final completion requires additional regulatory clearances.